Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational studyPietro De Placido, Grazia Arpino, Margherita Tafuro et al.|Frontiers in Oncology|2022Cited by 11